Study Design and Evaluation of Risk Minimization Measures: A Review of Studies Submitted to the European Medicines Agency for Cardiovascular, Endocrinology, and Metabolic Drugs
Crossref DOI link: https://doi.org/10.1007/s40264-017-0604-4
Published Online: 2017-11-09
Published Print: 2018-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mazzaglia, Giampiero http://orcid.org/0000-0003-4933-2148
Straus, Sabine M. J.
Arlett, Peter
da Silva, Daniela
Janssen, Heidi
Raine, June
Alteri, Enrica
License valid from 2017-11-09